Investigational drug · Phase 2
ML-004
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Autism Spectrum Disorder.
Phase 2Last checked: Nov 19, 2026Latest source record: Jul 20, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
2
1 still active
All registered trials
2
Any phase or sponsor naming "ML-004"
First trial start
2022
Sep 13, 2022
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "ML-004", any sponsor or status.
Conditions studied
As listed on its trial records.
- Autism Spectrum Disorder
Largest trials
Live from ClinicalTrials.gov: studies naming "ML-004" as an intervention, largest first.
- ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)Pivotal-lookingCompleted
MapLight TherapeuticsIndustry
NCT05081245 · 168 participants · Start Sep 13, 2022 · Primary completion Mar 10, 2026
Drug: ML-004 (IR)/(ER) tablet; ML-004 Placebo · For: Autism Spectrum Disorder
Sites: Dothan, Alabama; Phoenix, Arizona; Glendale, California · 29 sites in all
- ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)Active, not recruiting
MapLight TherapeuticsIndustry
NCT05889273 · 120 participants (planned) · Start Jun 1, 2023 · Primary completion Nov 2027
Drug: ML-004 (IR)/(ER) tablet · For: Autism Spectrum Disorder
Sites: Dothan, Alabama; Phoenix, Arizona; Glendale, California · 21 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Towards treatments targeting the gut to improve behavioural outcomes in autism spectrum disorder.
Munira MS, Stevens JE, Shahin W, et al. · J Neural Transm (Vienna) 2026
Also in development for Autism Spectrum Disorder
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.